Abstract:ABSTRACT HRS9432(A) is a long-acting echinocandin antifungal medication primarily used to treat invasive fungal infections, particularly invasive candidiasis. The safety, tolerability, and pharmacokinetic characteristics of HRS9432(A) injection were investigated in a randomized, double-blind, placebo-controlled, single- and multiple-ascending-dose Phase I study involving 56 healthy adult subjects. Doses ranging from 200 to 1200 mg were administered. Safety was continually monitored, including adverse events, clinical laboratory examinations, vital signs, 12-lead electrocardiograms, and physical examinations, while the pharmacokinetic profile within the body was evaluated. The results indicated that concentrations of HRS9432 peaked immediately after infusion, demonstrating essentially linear pharmacokinetic characteristics within the dosage range of 200–1,200 mg. It exhibited a low clearance rate and an extended half-life, with a clearance of approximately 0.2 L/h, a volume of distribution of around 40 L, and a half-life of approximately 140h following a single dose. The accumulation index for AUC0-τ after multiple doses ranged from 1.41 to 1.75. No severe adverse events occurred during the study, and the severity of all adverse events was mild or moderate. Therefore, the intravenous administration of HRS9432(A) in healthy Chinese adult subjects, either as multiple infusions of 200 to 600 mg (once a week, four doses) or as a single infusion of 900–1,200 mg, demonstrated overall good safety and tolerability. The pharmacokinetic exhibited essentially linear characteristics in the body, supporting a weekly dosing frequency for clinical applications and providing additional options for the treatment or prevention of invasive fungal infections. CLINICAL TRIALS This study is registered with the International Clinical Trials Registry Platform as ChiCTR2300073525 .

Phase I Clinical Tolerability Trial of Faropenem Sodium for Injection

Tolerability Trial of Peramivir Trihydrate and Sodium Chloride Injection in Healthy Volunteers

Pharmacokinetics of Meropenem Single Dose Intravenous in Healthy Volunteers

A First-in-human Safety, Tolerability and Pharmacokinetics study of Benapenem in Healthy Chinese Volunteers.

Multi-center Clinical Studies on Pazufloxacin Sodium Chloride Injection in Treatment for Acute Bacterial Infections

Parmacokinetics of pazufloxacin mesilate sodium chloride injection in Chinese healthy volunteers

A phase Ⅰ trial for the tolerability of Aoshaen injection

Study of the Safety and Tolerance of Human Albumin Microsphere, Injectable Suspension Octafluoropropane Formulation

A clinical randomized controlled trial of pazufloxacin injection in treatment of bacterial infection in 111 patients

Clinical efficacy and safety of peramivir trihydrate sodium chloride injection in the treatment of acute simple uncomplicated influenza

Evaluation Of The Pharmacokinetics And Safety Of Single And Multiple Ceftaroline Fosamil Infusions In Healthy Chinese And Western Subjects

Faropenem: review of a new oral penem

Pharmacokinetic, Pharmacokinetic/Pharmacodynamic, and Safety Investigations of Lefamulin in Healthy Chinese Subjects.

A randomized multicenter clinical study of injectable levofloxacin in the treatment of acute bacterial infections

Pharmacokinetics of pazufloxacin mesilate sodium chloride for injection

Tolerability and Pharmacokinetics of Biapenem Following Single and Multiple Intravenous Administrations in Healthy Chinese Subjects: an Open-Label, Randomized, Single-Center Study.

Tolerance of Antofloxacin Hydrochloride after Ascending Single Oral Dose Administration in Healthy Male Volunteers

Randomized control study of the use of faropenem for treating patients with pulmonary tuberculosis

Safety, tolerability, and pharmacokinetics of HRS9432(A) injection in healthy Chinese subjects: a phase-I randomized, double-blind, dose escalation, placebo-controlled study

Changes of PK/PD of Meropenem in patients with abdominal septic shock and exploration of clinical rational administration plan: a prospective exploratory study